CSI Market
Sign In | Register

Kaleido Biosciences Inc (KLDO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access KLDO Annual Cash Flow →
By examining cash flow figures across successive periods, users can identify shifts in Kaleido Biosciences Inc's cash generation and deployment strategy.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2021)
12 Months 		(Sep 30 2021) (Jun 30 2021) (Mar 31 2021) (Dec 31 2020)
Operating Activities
Income-90.29
Depreciation & amortization0.00
Amortization of Other Assets0.71
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation10.34
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.18
Gains Losses On Sales Of Assets0.01
Depreciation Depletion And Amortization Including Impact Of Loss On Disposal Of Property Plant And Equipment1.16
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.28
Increase (Decrease) in Accrued Liabilities-0.39
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.15
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-77.09
Investing Activities
Capital Expenditures-1.13
Sale of Capital Items0.44
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.69
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.02
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock70.40
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.34
Payments For Deferred Issuance Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities70.04
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-77.79
Total Cash Flow-7.75
4 historic quarters locked

Sign in to unlock the full Kaleido Biosciences Inc cash flow history.

Sign In Create Free Account

About Kaleido Biosciences Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-22-005256

Figures are derived from filed reports and may be restated. Historical data is subject to revision.